Accuracy of Genotyping Chips Called into Question
Accuracy of Genotyping Chips Called into Question
Chips used by some direct-to-consumer genetic testing firms display a false positive rate of upwards of 85 percent when screening for rare variants, a new study finds.  
Accuracy of Genotyping Chips Called into Question
Accuracy of Genotyping Chips Called into Question

Chips used by some direct-to-consumer genetic testing firms display a false positive rate of upwards of 85 percent when screening for rare variants, a new study finds.  

Chips used by some direct-to-consumer genetic testing firms display a false positive rate of upwards of 85 percent when screening for rare variants, a new study finds.  

direct to consumer
Do Devices that Monitor or Zap the Brain Live Up to Their Claims?
Do Devices that Monitor or Zap the Brain Live Up to Their Claims?
Diana Kwon | Jun 18, 2019
Direct-to-consumer neurotechnologies using EEG or tDCS are becoming increasingly popular, but some scientists are concerned about the lack of evidence for efficacy.
Company Offers Free Whole-Genome Sequencing for Data Sharers
Company Offers Free Whole-Genome Sequencing for Data Sharers
Shawna Williams | Nov 15, 2018
Nebula Genomics is among the first blockchain-based companies to reward users for contributing personal data for research.
Genes and Blues
Genes and Blues
Bob Grant | Oct 1, 2018
Learning about your own genetic idiosyncrasies comes with complex emotions.
Study Finds Inaccuracies in 40 Percent of DTC Genetic Testing Results
Study Finds Inaccuracies in 40 Percent of DTC Genetic Testing Results
Shawna Williams | Mar 28, 2018
An analysis of 49 patient samples finds high proportions of false positives and misinterpretation.
Theranos CEO Presents New Device
Theranos CEO Presents New Device
Kerry Grens | Aug 2, 2016
The troubled firm’s medical conference appearance didn’t deliver the evidence many hoped for.
Theranos in Criminal Probe
Theranos in Criminal Probe
Kerry Grens | Apr 19, 2016
Federal officials are investigating whether the diagnostics company misled investors.
TS Picks: February 24, 2016
TS Picks: February 24, 2016
Tracy Vence | Feb 24, 2016
High-profile stem cell research scandal; forthcoming direct-to-consumer genetics apps; GINA and life insurance
Following FDA OK, 23andMe to Expand Health Prediction
Following FDA OK, 23andMe to Expand Health Prediction
Kerry Grens | Oct 21, 2015
The personal genomics firm is ramping up its suite of disease-related genetic tests.